Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 1:40 AM
NCT ID:
NCT02773394
Eligibility Criteria:
Inclusion Criteria:
* Participants with diagnosis confirmed with Hepatitis C infection being followed into the reference centers
* There is no restriction on fibrosis stage or clinical liver disease
* There is no restriction for comorbities or coinfections
* Diagnosis of chronic HCV infection detected by anti-HCV (ELISA assays), HCV Ribonucleic acid (RNA) (polymerase chain reaction \[PCR\] reaction) with identification of genotype
Exclusion Criteria:
* Male or female participant with age greater than or equal to 18 years
* participating in another interventional clinical trial
* Treated participants who achieved sustained Virological Response (SVR)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02773394
Study Brief:
Protocol Section:
NCT02773394